Previous Article | Next Article 
Journal of Virology, September 1999, p. 7147-7152, Vol. 73, No. 9
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Unique Properties of the Large Antigen of Hepatitis
Delta Virus
Gloria
Moraleda,1
Steven
Seeholzer,1
Vadim
Bichko,1
Roland
Dunbrack,1
James
Otto,2 and
John
Taylor1,*
Fox Chase Cancer Center, Philadelphia,
Pennsylvania 19111-2497,1 and Duke
University Medical Center, Durham, North Carolina
27710-36862
Received 26 February 1999/Accepted 27 May 1999
 |
ABSTRACT |
The large form of the hepatitis delta virus (HDV) protein (L) can
be isoprenylated near its C terminus, and this modification is
considered essential for particle assembly. Using gel electrophoresis, we separated L into two species of similar mobilities. The slower species could be labeled by the incorporation of
[14C]mevalonolactone and is interpreted to be
isoprenylated L (Li). In serum particles, infected liver,
transfected cells, and assembled particles, 25 to 85% of L was
isoprenylated. Isoprenylation was also demonstrated by 14C
incorporation in vitro with a rabbit reticulocyte coupled
transcription-translation system. However, the species obtained
migrated even slower than that detected by labeling in vivo. Next, in
studies of HDV particle assembly in the presence of the surface
proteins of human hepatitis B virus, we observed the following. (i)
Relative to L, Li was preferentially assembled into
virus-like particles. (ii) Li could coassemble the
unmodified L and the small delta protein, S. (iii) In contrast, a form
of L with a deletion in the dimerization domain was both isoprenylated
and assembled, but it could not support the coassembly of S. Finally,
to test the expectation that the isoprenylation of L would increase its
hydrophobicity, we applied a phase separation strategy based on micelle
formation with the nonionic detergent Triton X-114. We showed the
following. (i) The unique C-terminal 19 amino acids present on L
relative to S caused a significant increase in the hydrophobicity. (ii) This increase was independent of isoprenylation. (iii) In contrast, other, artificial modifications at either the N or C terminus of S did
not increase the hydrophobicity. (iv) The increased hydrophobicity was
not sufficient for particle assembly; nevertheless, we speculate that
it might facilitate virion assembly.
 |
INTRODUCTION |
Human hepatitis delta virus (HDV) is
a subviral satellite of hepatitis B virus (HBV). A complete cycle of
HDV replication is dependent on the envelope proteins of HBV and the
expression of two related HDV proteins. The first is a 195-amino-acid
(aa) species, known as the small delta protein, S, which is essential for replication of the RNA genome (32). The second, which
arises as the consequence of a posttranscriptional RNA editing event (38), is 19 aa longer at the C terminus. This large delta
protein, L, is a dominant negative inhibitor of genome replication, the ability of S to support (8). It is also essential for
assembly of progeny virions (7).
Soon after L was found to be essential for particle assembly
(7), it was shown that it could be isoprenylated at a unique cysteine located 4 aa from the C terminus (19). This study
involved both delta protein expressed in mammalian cells and that
translated in vitro, with rabbit reticulocyte extracts. This
isoprenylation is exceptional; while various types of acylation are
known for proteins of other viruses, this is the only known example of
an isoprenylation (24). Such isoprenylation has also been
demonstrated when L is expressed in insect cells from a recombinant
baculovirus (26, 27) and has been inferred from assembly
studies carried out in yeast (48). A recent report used an
antibody specific for isoprenylated L (Li) in an
immunofluorescence assay; in transfected cells, modified L was largely
located within the nucleus (37).
Mutagenesis of this unique cysteine of L to serine blocks both the
isoprenylation and the assembly of L. Such findings have been used to
support the idea that the isoprenylation is essential for virus
assembly (19). Recent data obtained with an isoprenylation inhibitor, BZA-5B, further support this interpretation (18). An earlier study confirms that isoprenylation is necessary for assembly
but also shows that isoprenylation is not sufficient; the 15 aa located
upstream of the isoprenylation site are also critical (36).
Two different kinds of isoprenylation of host proteins, involving
addition of either a geranylgeranyl group or a farnesyl group, are
known (6). For the cellular proteins, isoprenylation typically requires three enzymatic steps (6). First, a
cysteine, located 4 aa from the C terminus, is covalently sulfhydryl
linked to either a 15-carbon farnesyl group or a 20-carbon
geranylgeranyl group; next, the 3 terminal aa are removed by an
endopeptidase; finally, the newly created C terminus is methylated.
The precise nature of the HDV L modification has been considered in
several studies. Initially a geranylgeranyl modification has been
considered in several studies. Initially a geranylgeranyl modification
was cited as an unpublished observation (16, 19). A more
recent study showed that in vivo only farnesylation was detected, while
in vitro, with purified transferases, both farnesylation and
geranylgeranylation could be achieved (42). Most recently, from a study based on the specificity, in other contexts, of the isoprenyl transferase inhibitor BZA-5B, it has been inferred that L is
farnesylated (16, 20). In the present study, we undertook to
determine for the first time the fraction of the L species that is
actually modified.
For host proteins, the three-step isoprenyl modification can sometimes
result in a protein with a somewhat increased electrophoretic mobility
(2, 21, 47). To determine whether isoprenylation of L
involved a mobility change, we used high-resolution gel electrophoresis to separate Li from unmodified L. Contrary to expectation,
the species Li that could be labeled in vivo by
incorporation of [14C]mevalonolactone migrated somewhat
less than L. We analyzed L from various sources and obtained
quantitation of the extent of this modification.
We also report here the application of a phase fractionation procedure
based on the ability of membrane proteins to associate with micelles of
the nonionic detergent Triton X-114 (5, 44). Our intent was
to clarify the hydrophobic properties of the various forms of delta
protein and how they might be relevant to HDV assembly. These studies
led us to conclude that even prior to isoprenylation L was relatively
more hydrophobic than S, presumably because of the novel 19 aa at
the C terminus.
 |
MATERIALS AND METHODS |
Plasmids.
pMEV (29), which expresses a mevalonic
acid transporter, was used to enhance isoprenyl labeling. pSV45H, from
Don Ganem, was used to express the surface proteins of HBV (sAg).
pSVTVA (1), which expresses the simian virus 40 T antigen,
was used to give a 16-fold enhancement of expression from pSVL-based
constructs in transfected Huh7 human hepatoblastoma
[41]) cells (3). For example, pDL444 and
pDL445 are constructs in pSVL (Pharmacia) which express S and L,
respectively (35). Similarly, pDL449 expresses L(
19-31),
a species with a deletion of sequences necessary for dimerization
(35), and pVB448 expresses L(C211A), with the cysteine at
position 211 changed to alanine (3). Also used was a
construct, pTW203, which expressed S with a histidine tag at the C
terminus (9). Constructs pVB101, pVB102, and pVB108, in
pcDNA3.1 (Invitrogen), use a cytomegalovirus immediate-early promoter
to express forms of S, L, and L(C211A), respectively, with 36 extra aa
at the N terminus, that include a histidine tag. Finally, pR5
V5 is a
bacterial vector which expresses high levels of unmodified S, via
codons which have been largely optimized for expression in bacteria
(9).
Protein purification.
Harmon Zuccola and Jim Hogle provided
the purified S protein expressed in bacteria by pR5
V5
(9). Various forms of S and L tagged with six histidines
were expressed in transfected Huh7 cells and purified via nickel
affinity procedures (9).
Transfection of mammalian cells.
Monolayers of Huh7 cells
were transfected by using either Lipofectamine or Lipofectamine Plus
(Life Technologies) according to the manufacturer's instructions.
In vivo isoprenyl labeling.
The strategy was a modification
of one previously described (42). Huh7 cells were
cotransfected with pMEV (which increases the uptake of exogenous
mevalonate) (29), pSVTVA, pDL444, and either pDL445 or
pVB448, expressing L or L(C211A), respectively. After 2 days,
Lovastatin (to inhibit the de novo synthesis of mevalonate by the cells
[10]) was added to the medium to a final concentration
of 30 µM. Following 1 h of incubation at 37°C, the medium was
aspirated and replaced with medium containing 20 µM Lovastatin and 50 µCi of [14C]mevalonolactone (American Radiolabeled
Chemicals) per ml. After 8 h of incubation at 37°C, the medium
was removed, and the cells were washed twice with phosphate-buffered
saline (PBS) and lysed in 300 µl of a buffer containing 100 mM NaCl,
20 mM Tris-HCl (pH 7.5), 2 mM MgCl2, and 1% Nonidet P-40.
Then, samples were subjected to sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) and electrotransferred to
nitrocellulose, and radioactivity was detected and quantitated by
direct contact with a bioimager screen (Fuji model BAS1000).
In vitro isoprenyl labeling.
A cDNA construct containing the
coding region of L was expressed via a T7 promoter in a coupled
transcription-translation system (Promega) as instructed by the
manufacturer except that all the amino acids in the reaction mixture
were unlabeled and [14C]mevalonolactone (1.25 mCi/ml) was
added to the mixture.
Gel electrophoresis and immunoblot analysis.
We used the
Laemmli procedure (34) with 12.5% acrylamide monomer and
0.72% bisacrylamide cross-linker. These changes, together with an
increase in the electrophoresis time, made possible the resolution of L
obtained from in vivo samples into two species. Only the slower
species, Li, could be labeled by 14C
incorporation, and it is deduced to be the isoprenylated form.
Assembly of HDV and into particles.
Huh7 cells were
transfected as described previously (46) on 100-mm-diameter
plates. Plasmid pSV45H was used for the expression of all three HBV sAg
proteins, along with the appropriate plasmids expressing forms of S and
L (46). After 8 days, cells were lysed in Laemmli buffer and
1/400 of the sample was subjected to SDS-PAGE. To assay for the release
of HDV particles, tissue culture medium was collected at 4, 6, and 8 days after transfection, clarified by centrifugation for 10 min at
1,000 rpm, and stored at
80°C. Then viral particles were pelleted
by ultracentrifugation through a 20% sucrose cushion containing 100 mM
NaCl, 10 mM Tris-HCl (pH 7.5), and 1 mM EDTA for 18 h at 23,000 rpm in a Beckman SW28 rotor at 4°C. The pellet was resuspended in 80 µl of Laemmli buffer, and one-fourth of the sample was analyzed by
SDS-PAGE. Results were quantitated as described above.
Triton X-114 phase separation.
Phase separation was carried
out by a modification of the method described by Bordier
(5). Samples were resuspended in Triton X-114 lysis buffer
(Tris-buffered saline [TBS; 10 mM Tris-HCl, {pH 7.4} 0.15 M NaCl,
1 mM EDTA] containing 1% Triton X-114). After 1 h on ice with
mild agitation, insoluble material was removed by centrifugation at
450 × g for 5 min. For the separation of the proteins,
supernatants were overlaid on a sucrose cushion buffer (6% sucrose and
0.06% Triton X-114 in TBS), and tubes were incubated for 10 min in a
37°C water bath. Tubes were centrifuged for 3 min at 200 × g at room temperature, thereby separating the aqueous phase as
the supernatant and the detergent phase as an oily drop in the bottom
of the tube. This oily drop was resuspended in TBS, and the separation
was repeated as before. Finally, the detergent and aqueous phases were
precipitated by adding 9 volumes of ethanol and analyzed by SDS-PAGE.
To eliminate protein-protein interactions during fractionation,
aurintricarboxylic acid was added to the buffers at a final
concentration of 100 µM.
 |
RESULTS |
Detection of Li by in vivo labeling and gel
electrophoresis.
Previous studies by others working with host cell
proteins have separated farnesylated from unfarnesylated species by gel electrophoresis (2, 21). Our initial objective was to obtain a similar separation of the unmodified form of L from the isoprenylated form, Li. Our strategy was first to obtain radioactive
labeling of the modified protein and then determine whether this
species could be separated from unmodified L, as detected by immunoblotting.
Others have been able to label L in vivo by means of the incorporation
of radioactive mevalonolactone, a precursor to the isoprenyl group
(19, 26, 27). As described in Materials and Methods, we used
such a strategy, along with certain modifications which greatly
increased the labeling efficiency. We tested the labeling of wild-type
L and, as a negative control, the labeling of S. As an additional
control, we also expressed a mutated form of L, L(C211A), that could no
longer be isoprenylated. After electrophoresis, the proteins were
electrotransferred to a nitrocellulose filter, and the 14C
label was detected with a bioimager (Fig.
1A, lanes 1 and 2). There was significant
labeling of a species of about the same electrophoretic mobility as
Large (lane 1). It can be seen that this protein was significantly more
highly labeled than any host protein, and it was not present in cells
transfected with the L(C211A) mutant (lane 2).

View larger version (58K):
[in this window]
[in a new window]
|
FIG. 1.
Isoprenylation of L as detected by 14C
labeling in vivo and immunoblotting. Huh7 cells were cotransfected and
labeled with [14C]mevalonolactone, after which the total
proteins were resolved by gel electrophoresis, followed by
electrotransfer, all as described in Materials and Methods. (A) Lanes 1 and 2, detection of 14C, presumably incorporated into
isoprenylated proteins; lanes 3 and 4, the same region of the filter
after immunoblotting to detect HDV proteins with
125I-staphylococcal A protein. Lanes 1 and 3 contain S and
L; lanes 2 and 4 contain S and the C211A mutant of L. (B to D)
Radioactivity profiles for lanes 1, 3, and 4, respectively. The slower
species of L, indicated as Li, was the only delta species
labeled with 14C (A, lanes 1 and 3) and was not present for
the mutated L (A, lanes 2 and 4); it is considered to be the
isoprenylated form of L.
|
|
Next we took the same filter and carried out an immunoblot analysis
with an antibody directed at all species of delta protein
followed by
detection with
125I-labeled staphylococcal A protein (Fig.
1A, lanes 3 and 4). We
now detected two species of L and one species of
S (lane 3). The
slower species of L had the same mobility as that
detected by
14C (lane 1), and it was not present in cells
transfected with the
L(C211A) mutant (lane 4). Therefore, we make the
initial designation
of this species as L
i.
A quantitation of the radioactivity profiles corresponding to lanes 1, 3, and 4 of Fig.
1A, is shown in Fig.
1B to D, respectively.
Figure
1C
shows that about 50% of the total L migrated as L
i.
With this gel electrophoretic separation and quantitation, we
determined the fraction of the total L that migrated as L
i
for these samples and for a series of other HDV-related samples.
The
results are summarized in Table
1. We
note that for all samples
tested, the extent of modification was always
less than 100%;
in some cases it reached as high as 85%. As expected,
for the
L(C211A) mutant, no modification (<5%) was detected.
Detection of Li by labeling in vitro in a rabbit
reticulocyte lysate.
Previous studies show that during translation
of L in a rabbit reticulocyte lysate the protein can become
isoprenylated (19). Furthermore, the isoprenylated species
was cited as migrating more slowly than unmodified L. As shown in Fig.
2, we used a coupled transcription-translation system, in the presence of
[14C]mevalonolactone, to determine the electrophoretic
mobility of the labeled L (lane 3) relative to that species of L
labeled in vivo (lane 1). The in vitro sample was significantly slower,
a finding confirmed by electrophoresis of both samples in the same well
(lane 2). Our interpretation (see Discussion) is that in vitro, the
rabbit reticulocyte lysate carries out only the first of the normal
three steps of isoprenylation.

View larger version (133K):
[in this window]
[in a new window]
|
FIG. 2.
Comparison of isoprenylation of L as detected by
14C labeling in vivo and in vitro. Labeling was carried out
in vivo, as for Fig. 1, or in vitro, using a coupled
transcription-translation system. Samples were subject to
electrophoresis as for Fig. 1, followed by electrotransfer and then
direct quantitation of 14C with a bioimager. Lanes 1 and 3, the in vivo and in vitro samples, respectively; lane 2, a mixture of
the two samples.
|
|
Assembly and coassembly.
Previous studies show that with the
help of the envelope proteins of HBV, the HDV L protein is assembled
into particles (7, 46). Also, studies with L mutants
(19) and isoprenylation inhibitors (18) indicate
that Li is essential for assembly. Furthermore, there are
forms of the delta protein, such as S, which in the absence of
Li cannot be assembled into particles yet in the presence
of Li can be found in particles. This phenomenon, which we
will call coassembly, depends on the ability of the coassembled
proteins to form multimers with Li (35).
Previous studies of HDV assembly and coassembly are deficient in that
they included neither separation nor quantitation of L and
Li. The following studies solve this deficiency for several
different experimental situations.
In the first experiment, a comparison was made between L
i
in infected cultured cells and the particles released from those
cells.
Cells were cotransfected with plasmids expressing L and
S, along with a
plasmid that expressed the envelope proteins of
HBV, HBV sAg. Gel
analysis of the transfected cells showed that
less than half of L was
isoprenylated (Fig.
3, lane 2). In
contrast,
for the released particles, the majority of L was
isoprenylated
(Fig.
3, lane 3). In this respect, the released particles
were
very similar to those detected in serum particles (Fig.
3, lane
1)
and infected liver (data not shown). A detailed quantitation
of this
assembly experiment is presented in Table
2, experiment
1. Around 7% of the
intracellular species designated L
i was released into
particles. In contrast, only about 1.2% of
either S or the unmodified
L was released into particles. Our
interpretation is that S and L were
coassembled by L
i. Note that in this situation the
efficiency of coassembly was
about six times less than the efficiency
of assembly.

View larger version (93K):
[in this window]
[in a new window]
|
FIG. 3.
Assembly of L and S into virus-like particles in the
presence of the envelope proteins of HBV. As described in Materials and
Methods, following cotransfection of Huh7 cells, we used an immunoblot
analysis to assay the cells (lane 2) and tissue culture medium (lane 3)
for the presence of delta proteins. Lane 1 is a control of HDV
particles in the serum of an infected woodchuck.
|
|
Previous studies have characterized a form of L with a deletion in the
dimerization domain; this protein has either a significantly
reduced
ability or a total inability to form dimers (
35). This
mutant, designated L(

19-31), was expressed in cells along with
HDV
S and the HBV sAg. By immunoblotting we detected only a single,
relatively broad band, which we interpret as containing both
isoprenylated
and unmodified forms of the mutant L (data not shown). As
summarized
in Table
2, experiment 2, 1.22% of the mutant protein was
assembled
into particles. In contrast, 24 times less S was found in
particles.
Our interpretation is that L(

19-31) could be
isoprenylated to
some extent and that the 1.22% assembled into
particles was virtually
all isoprenylated. We confirmed the
modification by separate studies
with
[
14C]mevalonolactone labeling, just as in Fig.
1 (data
not shown).
In contrast, we infer that unmodified L(

19-31) was,
like S, coassembled
at least 24 times less
efficiently.
Others have shown that forms of L with the mutation C211S are unable to
support particle assembly, presumably because of an
inability to be
isoprenylated (
26). We tested a similar mutant,
L(C211A),
and observed <0.1% assembly (Table
2, experiment 5).
However, when we
expressed L(C211A) along with h6L, a form of
L with a histidine tag at
the N terminus, we observed 1.37% assembly
(Table
2, experiment 3). We
interpret this as coassembly. The
histidine-tagged protein did not give
electrophoretic separation
of the isoprenylated and unmodified forms;
however, in total,
1.61% was assembled into particles (Table
2,
experiment 3). Separate
studies with
[
14C]mevalonolactone, as in Fig.
1, showed that h6L could
be labeled
(data not shown), consistent with some of this protein being
isoprenylated.
As an additional negative control, we examined assembly of S, in the
absence of other forms of delta antigen, and detected
only 0.2% (Table
2, experiment 4). We interpret this amount as
a background level for
our assembly
assay.
Hydrophobicity.
It is known that acylation of host or viral
proteins can make them markedly more hydrophobic and likely to make
protein-protein and/or protein-lipid interactions (40).
Extrapolation of these findings to HDV has been used to rationalize why
the L protein becomes isoprenylated. In an attempt to directly test
this extrapolation, we made use of an assay for protein hydrophobicity
based on the temperature-sensitive micelle formation achieved with the
nonionic detergent Triton X-114. On a shift from 4 to 37°C, this
detergent will form micelles which trap hydrophobic proteins,
especially ones known to be integral membrane proteins (5).
When we first applied this method to various forms of L and S, we found
that protein-protein interactions perturbed the results.
For example,
fractionation of the RNP complexes present within
serum virus, followed
by immunoblot assays, gave results with

87% of both L and S in the
detergent phase (data not shown).
Thus, we modified the fractionation
procedure by the addition
throughout of aurintricarboxylic acid (an
agent known to interfere
with protein-protein interactions
[
22]) to 100 µM. We then found
that most of the S
left the detergent phase whereas most of the
L remained (Fig.
4A). Using this modification, we assayed
a series
of additional forms of the delta proteins for their
hydrophobicity,
as shown in Fig.
4B and C. An unexpected finding was
that each
of the forms of L tested, regardless of whether it was
isoprenylated,
partitioned into the detergent phase. In contrast, each
of the
tested forms of S behaved as hydrophilic. The addition of a
histidine
tag to either the N or C terminus of S did not change its
hydrophilicity.
In contrast, addition to the C terminus of the 19-aa
segment which
converts S to L did make the protein hydrophobic.

View larger version (44K):
[in this window]
[in a new window]
|
FIG. 4.
Triton X-114 phase separation of delta proteins. As
described in Materials and Methods, samples containing different forms
of the delta proteins were separated into three fractions (insoluble,
detergent, and aqueous; lanes 1 to 3, respectively) and then assayed by
gel electrophoresis and immunoblotting. (A) Nonidet P-40-disrupted
particles from the serum of an HDV-infected woodchuck. (B and C) Phase
separations for different combinations of purified delta proteins, as
indicated on the right. The immunoblots were quantitated to determine
for each delta protein the fraction of the total soluble protein
detected in the detergent phase; the results are indicated at the far
right.
|
|
 |
DISCUSSION |
There are many examples of viral proteins that undergo
posttranslational acylation, that is, modifications in which various fatty acid prosthetic groups are added; it is considered that these
modifications make the viral proteins more hydrophobic and are
equivalent to "greasing the wheels of assembly" (24).
HDV L is the only example of an animal virus protein for which the acyl
modification is an isoprenylation, even though there are speculations
based on C-terminal sequences that there may be similar modifications
for other animal virus proteins (16). We have provided here
the first evidence that modified and unmodified forms of L are present
both in infected liver and in released virions. We have obtained the
first quantitation of the extent of this modification both during
natural infections and in transfected cultured cells (Fig. 1; Table 1).
For natural infections, the observed level of modification was high
both in liver and in serum particles, and so we were unable to
demonstrate whether isoprenylation was essential in such situations
(Table 1). However, in experiments with transfected cells we were able
to detect preferential assembly of Li into virus-like
particles (Fig. 3; Table 2).
We observed that during electrophoresis Li migrated more
slowly than L (Fig. 1C). This was in contrast to our expectation based on studies of other modified proteins, where farnesylated proteins migrate somewhat faster than the unmodified protein (2, 21, 47). It is possible that this discrepancy for Li is
due to a difference in the levels of phosphorylation between L and
Li. However, contrary to a previous study (3),
we were unable to detect any difference by two-dimensional gel
electrophoresis (data not shown).
We confirmed the result of others that the L protein can be
isoprenylated in vitro in a rabbit reticulocyte lysate (16, 19,
42). However, we also showed that this protein migrated even more
slowly than that labeled in vivo (Fig. 2). One interpretation of this
mobility difference, based on published studies of isoprenylation using
rabbit reticulocyte lysates (11), is that the species underwent only the first rather than all three steps of the
isoprenylation. That is, it did not undergo either the tripeptide
removal or the final carboxymethylation. Thus, we calculate that L
modified in vitro would be 367 Da larger than L modified in vivo.
Previous studies indicate that the actual in vivo modification of L
involves primarily a farnesyl rather than a geranylgeranyl group
(42). We attempted to further clarify this issue by using mass spectrometry but were unsuccessful, for both the intact protein and C-terminal fragment released by proteolysis, in obtaining reproducible analyses (unpublished observations). Such difficulties are
interpreted as due to the hydrophobicity of the modified C terminus
because no difficulties were encountered for the unmodified protein,
for a mutant unmodifiable protein, or for non-C-terminal proteolytic fragments.
HBV is the natural helper virus of HDV. Expression of the HBV envelope
proteins, HBV sAg, leads to extensive particle formation (13). In cultured cells, expression of these HBV sAg can
lead to the assembly of delta proteins. Previous studies have shown that expression of L is essential for assembly (7, 46) and provided indirect evidence that this is mediated via Li
interacting with HBV sAg (19). We provide here direct
evidence that Li is preferentially assembled (Fig. 3; Table
2). We observed up to 7% of the Li being assembled and
released in an 8-day period (Table 2).
Our data and those of Glenn et al. (17, 18) show that it is
the isoprenylation of L that is needed for assembly. Still unknown is
whether this modification directly or indirectly mediates the
interaction with the envelope protein(s) of the helper virus. We favor
an indirect mechanism since HDV particles can be assembled not only by
the envelope proteins of HBV but also by those of woodchuck hepatitis
virus (43).
We have also found two mutated forms of L can be both isoprenylated and
assembled. In one case, the N terminus was extended with a histidine
tag (Table 2 and data not shown). In the other case, we used a deletion
in the region near the N terminus that is essential for the
dimerization and multimerization of the delta antigen (35).
Our studies show that isoprenylation does not depend on multimerization.
For some time it has been known that certain forms of delta protein,
which cannot be assembled by HBV sAg, can nevertheless be assembled if
L and Li are present. To distinguish this latter process
from assembly, we call it coassembly. As previously shown
(35) and confirmed here (Table 2), coassembly of a delta
protein depends on its ability to dimerize with L and/or
Li. With our ability to separate and quantitate L and
Li, we have been able to show that unmodified L is also
coassembled. In this respect, L is no different from S or from mutant
forms of L that cannot be isoprenylated. Others have studied C(211)S mutants of L (25), and we have obtained similar results with C(211)A (Table 2).
This brings us to the question of the hydrophobicity of delta proteins.
We expected that Li might be more hydrophobic than either S
or unmodified L. Therefore, we tested these and some related proteins
in a phase separation assay (Fig. 4). S and two S-related proteins were
all hydrophilic. However, we found that not only Li but
also unmodified L, the mutant L(C211A), and an L-related protein were
all more hydrophobic. A limitation of the assay was that we could not
tell whether Li was more hydrophobic than L; other studies
show that both addition of the isoprenyl group and the final
methylation each dramatically increase the membrane affinity of a
protein (15). However, our data do support the
interpretation that the 19 aa unique to the C terminus of L, even prior
to isoprenylation, confers a definite increase in hydrophobicity. We
note that the sequence of this segment, WDILFPADPPFSPQSCRPQ,
is more hydrophobic than most of the protein sequence, which is
otherwise highly charged. It contains 11 hydrophobic aa, including five
prolines. In Fig. 5A, we show the
secondary structure predictions from a number of protein folding programs as well as a consensus prediction. The 19-aa C terminus is
predicted to be mostly coil in structure because of the many prolines,
although the first few amino acids may form the second strand of a
hairpin. If so, one face of this hairpin might be very hydrophobic
(residues L and I in the first strand; W, I, and F in the second
strand). In Fig. 5B, we show the prediction of two coiled-coil segments
in the protein according to the COILS algorithm (39). The
first segment of coiled coil is found in the crystal structure of
Zuccola et al. (50). There is also clearly another
coiled-coil domain in residues 100 to 150. There is evidence that this
second region may also allow some dimerization in vitro
(49); however, in the present study it was not sufficient to
allow coassembly.

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 5.
Predicted secondary structure of the large form of HDV
antigen. (A) The protein sequence of Kuo et al. (33) was
submitted to five different folding programs, PHD (45), DSC
(30), nnpredict (31), predator (12),
and SIMPA (4). The results and also a consensus folding are
indicated. (B) Prediction of the coiled-coil segments by using the
COILS algorithm (39).
|
|
An equally important questions is whether the detected
isoprenylation-independent increase in hydrophobicity of L has
biological relevance. We speculate that this increase might facilitate
necessary interactions between this protein and the relevant isoprenyl
transferase(s). In addition, our finding may help explain an earlier
report of Lee et al. (36). These authors showed that the
C-terminal 19 aa of L had a necessary role in virus assembly that was
separate from the necessary role of acting as a site for
isoprenylation. It is clear from our results that the increase in
hydrophobicity, in the absence of isoprenylation per se, was not
sufficient to direct assembly; it did not even directly facilitate
coassembly, because S and L were coassembled with similar efficiencies
(Table 2). One possible function is that the increased hydrophobicity enables L to reach a membrane site; it may be a second signal for
membrane anchoring (23). Another possibility, not mutually exclusive of the first, is that the hydrophobicity is a facilitator of
protein-protein associations, for example, at a membrane site (14). After all, we expect particle assembly to occur at the endoplasmic reticulum and to involve interactions between delta proteins and HB sAg (13, 28).
 |
ACKNOWLEDGMENTS |
J.T. was supported by grants AI-26522 and CA-06927 from NIH and
by an appropriation from the Commonwealth of Pennsylvania. J.O. was
funded by a fellowship from the Leukemia Society of America.
Harmon Zuccola and James Hogle provided purified recombinant S protein.
Certain essential vectors were provided by Don Ganem and F. Asselbergs.
Valuable help and advice was given by Said Sebti, Matt Bockol,
Ting-Ting Wu, and Kate Dingle. Constructive comments on the manuscript
were provided by William Mason.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Fox Chase Cancer
Center, 7701 Burholme Ave., Philadelphia, PA 19111-2497. Phone: (215) 728-2436. Fax: (215) 728-3616. E-mail:
JM_Taylor{at}FCCC.edu.
 |
REFERENCES |
| 1.
|
Asselbergs, F. A. M., and P. Grand.
1993.
A two-plasmid system for transient expression of cDNAs in primate cells.
Anal. Biochem.
209:327-331[Medline].
|
| 2.
|
Bernard, E. J.,
G. Kao,
A. D. Cox,
S. M. Sebti,
A. D. Hamilton, and R. J. Muschel.
1996.
The farnesyltransferase inhibitor FTI-277 radiosensitizes H-ras-transformed rat embryo fibroblasts.
Cancer Res.
56:1727-1730[Abstract/Free Full Text].
|
| 3.
|
Bichko, V.,
S. Barik, and J. Taylor.
1997.
Phosphorylation of the hepatitis delta virus antigens.
J. Virol.
71:512-518[Abstract].
|
| 4.
|
Biou, V.,
J. F. Gibrat,
J. M. Levin,
J. Robson, and J. Garnier.
1988.
Secondary structure prediction: combination of three different methods.
Protein Eng.
2:185-191[Abstract/Free Full Text].
|
| 5.
|
Bordier, C.
1981.
Phase separation of integral membrane proteins in Triton X-114 solution.
J. Biol. Chem.
256:1604-1607[Abstract/Free Full Text].
|
| 6.
|
Casey, P. J., and M. C. Seabra.
1996.
Protein prenyltransferases.
J. Biol. Chem.
271:5289-5292[Free Full Text].
|
| 7.
|
Chang, F. L.,
P. J. Chen,
S. J. Tu,
M. N. Chiu,
C. J. Wang, and D. S. Chen.
1991.
The large form of hepatitis antigen is crucial for the assembly of hepatitis virus.
Proc. Natl. Acad. Sci. USA
88:8490-8494[Abstract/Free Full Text].
|
| 8.
|
Chao, M.,
S.-Y. Hsieh, and J. Taylor.
1990.
Role of two forms of the hepatitis delta virus antigen: evidence for a mechanism of self-limiting genome replication.
J. Virol.
64:5066-5069[Abstract/Free Full Text].
|
| 9.
|
Dingle, K.,
V. Bichko,
H. Zuccola,
J. Hogle, and J. Taylor.
1998.
Initiation of hepatitis delta virus genome replication.
J. Virol.
72:4783-4788[Abstract/Free Full Text].
|
| 10.
|
Endo, A.
1992.
The discovery and development of HMG-CoA reductase inhibitors.
J. Lipid Res.
33:1569-1582[Medline].
|
| 11.
|
Farh, L.,
D. A. Mitchell, and R. J. Deschenes.
1995.
Farnesylation and proteolysis are sequential, but distinct steps in the CaaX box modification pathway.
Arch. Biochem. Biophys.
318:113-121[Medline].
|
| 12.
|
Frishman, D., and P. Argos.
1997.
Seventy-five percent accuracy in protein secondary structure prediction.
Proteins
27:329-335[Medline].
|
| 13.
|
Ganem, D.
1991.
Assembly of hepadnaviral virions and subviral particles.
Curr. Top. Microbiol. Immunol.
168:61-83[Medline].
|
| 14.
|
Garoff, H.,
R. Hewson, and D.-J. E. Opstelten.
1998.
Virus maturation by budding.
Microbiol. Mol. Biol. Rev.
62:1171-1190[Abstract/Free Full Text].
|
| 15.
|
Ghomashchi, F.,
X. Zhang,
L. Liu, and M. H. Gelb.
1995.
Binding of prenylated and polybasic peptides to membranes: affinities and intervesicle exchange.
Biochemistry
34:11910-11918[Medline].
|
| 16.
|
Glenn, J. S.
1995.
Prenylation and virion morphogenesis, p. 83-94.
In
G. Dinter-Gottlieb (ed.), The unique hepatitis delta virus. R. G. Landes, Co., Austin, Tex.
|
| 17.
|
Glenn, J. S.
1999.
Shutting the door on hepatitis delta virus (HDV): sensitivity to prenylation inhibition prompts new therapeutic strategy.
Viral Hepat. Rev.
5:13-26.
|
| 18.
|
Glenn, J. S.,
J. C. Marsters, Jr., and H. B. Greenberg.
1998.
Use of a prenylation inhibitor as a novel antiviral agent.
J. Virol.
72:9303-9306[Abstract/Free Full Text].
|
| 19.
|
Glenn, J. S.,
J. A. Watson,
C. M. Havel, and J. O. White.
1992.
Identification of a prenylation site in the delta virus large antigen.
Science
256:1331-1333[Abstract/Free Full Text].
|
| 20.
|
Glenn, J. S., and J. M. White.
1991.
trans-dominant inhibition of human hepatitis delta virus genome replication.
J. Virol.
65:2357-2361[Abstract/Free Full Text].
|
| 21.
|
Gutierrez, L.,
A. I. Magee,
C. J. Marshall, and J. F. Hancock.
1989.
Post-translational processing of p21ras is two-step and involves carboxymethylation and carboxy-terminal proteolysis.
EMBO J.
8:1093-1099[Medline].
|
| 22.
|
Hallick, R. B.,
B. K. Chelm,
P. W. Gray, and E. M. Orozco.
1977.
Use of aurintricarboxylic acid as an inhibitor of nucleases during nucleic acid isolation.
Nucleic Acids Res.
4:3055-3063[Abstract/Free Full Text].
|
| 23.
|
Hancock, J. F.,
H. Paterson, and C. J. Marshall.
1990.
A polybasic domain or palmitoylation is required in addition to the CAAX motif to localize p21ras to the plasma membrane.
Cell
63:133-139[Medline].
|
| 24.
|
Hruby, D. E., and C. A. Franke.
1993.
Viral acylproteins: greasing the wheels of assembly.
Trends Microbiol.
1:20-25[Medline].
|
| 25.
|
Hwang, S. B., and M. M. C. Lai.
1994.
Isoprenylation masks a conformational epitope and enhances trans-dominant inhibitory function of the large hepatitis delta antigen.
J. Virol.
68:2958-2964[Abstract/Free Full Text].
|
| 26.
|
Hwang, S. B., and M. M. C. Lai.
1993.
Isoprenylation mediates direct protein-protein interactions between hepatitis large delta antigen and hepatitis B virus surface antigen.
J. Virol.
67:7659-7662[Abstract/Free Full Text].
|
| 27.
|
Hwang, S. B.,
C.-Z. Lee, and M. M. C. Lai.
1992.
Hepatitis delta antigen expressed by recombinant baculoviruses: comparison of biochemical properties and post-translational modifications between the large and small forms.
Virology
190:413-422[Medline].
|
| 28.
|
Jenna, S., and C. Sureau.
1998.
Effect of mutations in the small envelope protein of hepatitis B virus on assembly and secretion of hepatitis delta virus.
Virology
251:176-186[Medline].
|
| 29.
|
Kim, C. M.,
J. L. Goldstein, and M. S. Brown.
1992.
cDNA cloning of MEV, a mutant protein that facilitates cellular uptake of mevalonate, and identification of the point mutation responsible for its gain of function.
J. Biol. Chem.
267:23113-23121[Abstract/Free Full Text].
|
| 30.
|
Kinh, R. D.,
M. Saqi,
R. Sayle, and M. J. Sternberg.
1997.
DSC: public domain protein secondary structure prediction.
Comput. Appl. Biosci.
13:473-474[Free Full Text].
|
| 31.
|
Kneller, D. G.,
F. E. Cohen, and R. Langridge.
1990.
Improvements in secondary structure prediction by an enhanced neural network.
J. Mol. Biol.
214:171-182[Medline].
|
| 32.
|
Kuo, M. Y.-P.,
M. Chao, and J. Taylor.
1989.
Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen.
J. Virol.
63:1945-1950[Abstract/Free Full Text].
|
| 33.
|
Kuo, M. Y.-P.,
J. Goldberg,
L. Coates,
W. Mason,
J. Gerin, and J. Taylor.
1988.
Molecular cloning of hepatitis delta virus RNA from an infected woodchuck liver: sequence, structure, and applications.
J. Virol.
62:1855-1861[Abstract/Free Full Text].
|
| 34.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature (London)
227:680-685[Medline].
|
| 35.
|
Lazinski, D. W., and J. M. Taylor.
1993.
Relating structure to function in the hepatitis delta virus antigen.
J. Virol.
67:2672-2680[Abstract/Free Full Text].
|
| 36.
|
Lee, C.-Z.,
P.-J. Chen,
M. Lai, and D.-S. Chen.
1994.
Isoprenylation of large hepatitis delta antigen is necessary but not sufficient for hepatitis delta virus assembly.
Virology
199:169-175[Medline].
|
| 37.
|
Lin, H.-p.,
S.-C. Hsu,
J.-C. Wu,
I.-J. Sheen,
B.-S. Yan, and W.-J. Syu.
1999.
Localization of isoprenylated antigen of hepatitis delta virus by anti-farnesyl antibodies.
J. Gen. Virol.
80:91-96[Abstract].
|
| 38.
|
Luo, G.,
M. Chao,
S.-Y. Hsieh,
C. Sureau,
K. Nishikura, and J. Taylor.
1990.
A specific base transition occurs on replicating hepatitis delta virus RNA.
J. Virol.
64:1021-1027[Abstract/Free Full Text].
|
| 39.
|
Lupas, L.,
M. Van Dyke, and J. Stock.
1991.
Predicting coiled coils from protein sequences.
Science
252:1162-1164[Free Full Text].
|
| 40.
|
Marshall, C. J.
1993.
Protein prenylation: a mediator of protein-protein interactions.
Science
259:1865-1866[Free Full Text].
|
| 41.
|
Nakabayashi, H.,
K. Taketa,
K. Miyano,
T. Yamane, and J. Sato.
1982.
Growth of human hepatoma cell lines with differentiated functions in chemically defined medium.
Cancer Res.
42:3858-3863[Abstract/Free Full Text].
|
| 42.
|
Otto, J. C., and P. J. Casey.
1996.
The hepatitis delta virus large antigen is farnesylated both in vitro and in animal cells.
J. Biol. Chem.
271:4569-4572[Abstract/Free Full Text].
|
| 43.
|
Ponzetto, A.,
P. J. Cote,
H. Popper,
B. H. Hoyer,
W. T. London,
E. C. Ford,
F. Bonino,
R. H. Purcell, and J. L. Gerin.
1984.
Transmission of the hepatitis B virus-associated agent to the eastern woodchuck.
Proc. Natl. Acad. Sci. USA
81:2208-2212[Abstract/Free Full Text].
|
| 44.
|
Pryde, J. G.
1986.
Triton X-114: a detergent that has come in from the cold.
Trends Biochem. Sci.
11:160-163.
|
| 45.
|
Rost, B.
1996.
PHD: predicting one-dimensional protein structure by profile based neural networks.
Methods Enzymol.
266:525-539[Medline].
|
| 46.
|
Ryu, W.-S.,
M. Bayer, and J. Taylor.
1992.
Assembly of hepatitis delta virus particles.
J. Virol.
66:2310-2315[Abstract/Free Full Text].
|
| 47.
|
Sasseville, A. M.-J., and Y. Raymond.
1995.
Lamin A precursor is localized to intranuclear foci.
J. Cell Sci.
108:273-285[Abstract].
|
| 48.
|
Wu, H.-L.,
P.-J. Chen,
J.-J. Mu,
W.-K. Chi,
T.-L. Kao,
L.-H. Hwang, and D.-S. Chen.
1997.
Assembly of hepatitis delta virus-like empty particles in yeast.
Virology
236:374-381[Medline].
|
| 49.
|
Xia, Y.-P., and M. M. C. Lai.
1992.
Oligomerization of hepatitis delta antigen is required for both the trans-activating and trans-dominant inhibitory activities of the delta antigen.
J. Virol.
66:6641-6648[Abstract/Free Full Text].
|
| 50.
|
Zuccola, H. J.,
J. E. Rozzelle,
S. M. Lemon,
B. W. Erickson, and J. M. Hogle.
1998.
Structural basis of the oligomerization of hepatitis delta antigen.
Structure
6:821-830[Medline].
|
Journal of Virology, September 1999, p. 7147-7152, Vol. 73, No. 9
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Gudima, S. O., Chang, J., Taylor, J. M.
(2006). Restoration in vivo of defective hepatitis delta virus RNA genomes. RNA
12: 1061-1073
[Abstract]
[Full Text]
-
Chang, J., Nie, X., Gudima, S., Taylor, J.
(2006). Action of Inhibitors on Accumulation of Processed Hepatitis Delta Virus RNAs.. J. Virol.
80: 3205-3214
[Abstract]
[Full Text]
-
O'Malley, B., Lazinski, D. W.
(2005). Roles of Carboxyl-Terminal and Farnesylated Residues in the Functions of the Large Hepatitis Delta Antigen. J. Virol.
79: 1142-1153
[Abstract]
[Full Text]
-
Huang, Y.-H., Wu, J.-C., Hsu, S.-C., Syu, W.-J.
(2003). Varied Immunity Generated in Mice by DNA Vaccines with Large and Small Hepatitis Delta Antigens. J. Virol.
77: 12980-12985
[Abstract]
[Full Text]
-
Moraleda, G., Dingle, K., Biswas, P., Chang, J., Zuccola, H., Hogle, J., Taylor, J.
(2000). Interactions between Hepatitis Delta Virus Proteins. J. Virol.
74: 5509-5515
[Abstract]
[Full Text]